0001562180-17-003957.txt : 20171219 0001562180-17-003957.hdr.sgml : 20171219 20171219210529 ACCESSION NUMBER: 0001562180-17-003957 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171216 FILED AS OF DATE: 20171219 DATE AS OF CHANGE: 20171219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robbins Andrew R CENTRAL INDEX KEY: 0001590157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16633 FILM NUMBER: 171265581 MAIL ADDRESS: STREET 1: C/O 3200 WALNUT ST CITY: BOULDER STATE: CO ZIP: 80301 FORMER NAME: FORMER CONFORMED NAME: Robbins Andrews R DATE OF NAME CHANGE: 20131025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2017-12-16 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001590157 Robbins Andrew R C/O ARRAY BIOPHARMA INC. 3200 WALNUT ST BOULDER CO 80301 false true false false COO Common Stock 2017-12-16 4 M false 13082.00 0.00 A 49766.00 D Common Stock 2017-12-16 4 F false 6094.00 10.92 D 43672.00 D Common Stock 2017-12-18 4 M false 200000.00 5.14 A 243672.00 D Common Stock 2017-12-18 4 M false 20366.00 4.91 A 264038.00 D Common Stock 2017-12-18 4 M false 89634.00 4.91 A 353672.00 D Common Stock 2017-12-18 4 M false 87500.00 4.63 A 441172.00 D Common Stock 2017-12-18 4 S false 282874.00 10.72 D 158298.00 D Restricted Stock Units 0.00 2017-12-16 4 M false 13082.00 0.00 D 2020-12-16 Common Stock 13082.00 39249.00 D Restricted Stock Units 0.00 2017-12-16 4 A false 55875.00 0.00 A 2021-12-17 Common Stock 55875.00 55875.00 D Stock Option (Right to Buy) 10.92 2017-12-16 4 A false 335250.00 0.00 A 2027-12-16 Common Stock 335250.00 335250.00 D Stock Option (Right to Buy) 5.14 2017-12-18 4 M false 200000.00 0.00 D 2022-07-31 Common Stock 200000.00 0.00 D Stock Option (Right to Buy) 4.91 2017-12-18 4 M false 20366.00 0.00 D 2017-07-23 2023-03-28 Common Stock 20366.00 0.00 D Stock Option (Right to Buy) 4.91 2017-12-18 4 M false 89634.00 0.00 D 2023-03-28 Common Stock 89634.00 0.00 D Stock Option (Right to Buy) 4.63 2017-12-18 4 M false 87500.00 0.00 D 2024-04-01 Common Stock 87500.00 87500.00 D Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on December 27, 2016 as a result of the vesting of one fourth of such RSUs. The option vests in four equal annual installments beginning on December 16, 2018. The option vested in four equal annual installments beginning on July 23, 2013. The option vested in four equal annual installments beginning on July 23, 2014. The option vested in four equal annual installments beginning on April 1, 2015. Includes 19,687 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs. Represents shares withheld to satisfy tax withholding obligations of the reporting person. Includes 19,687 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs. These trades were made pursuant to a Rule 10b5-1 trading plan. The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request. The RSUs vested on December 16, 2017. Consists of remaining unvested RSUs awarded to the reporting person for no additional cash consideration on December 16, 2016, which vest in three equal remaining installments beginning December 16, 2018, and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The grant of these RSUs were previously reported on a Table II of a form 4 filed by the reporting person. Consists of RSUs awarded to the reporting person for no additional cash consideration each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock. The RSUs vest and will be settled in stock in four equal annual installments beginning on December 16, 2018. Jason Haddock, attorney-in-fact for Andrew R. Robbins 2017-12-19